Depletion or inhibition of CDK1 with microRNAs or small molecular compounds has been shown to lead to reduced clonogenicity by arresting cells in the S–G2 and G2–M phases of the cell cycle and inducing apoptosis in HCC cell lines [44–47]. The gene discussed is CDK1; the disease is hepatocellular carcinoma.